About
Advisor since 2025 supporting the biopharmaceutical team. He is CEO of IFM Therapeutics and previously served as Global Head of BD&L for the Novartis Institutes for Biomedical Research.
Colleagues at Lightstone Ventures
Brendan Kelly
Principal at Lightstone Ventures
Caroline Gaynor
Partner at Lightstone Ventures
Christina Isacson
Partner at Lightstone Ventures
Christina Isacson, Ph.D.
Partner at Lightstone Ventures
Doug Treco
Advisor at Lightstone Ventures
Doug Treco, Ph.D.
Advisor at Lightstone Ventures
Frank D. Lee
Advisor at Lightstone Ventures
H. Martin Seidel, Ph.D.
Advisor at Lightstone Ventures